Drug Shortage Report for SODIUM CHLORIDE 3% INJ
| Report ID | 168709 |
| Drug Identification Number | 00060232 |
| Brand name | SODIUM CHLORIDE 3% INJ |
| Common or Proper name | 3% Sodium Chloride |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | SODIUM CHLORIDE |
| Strength(s) | 3G |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 250 mL (JB1352) |
| ATC code | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-09-07 |
| Actual start date | 2022-09-07 |
| Estimated end date | 2022-09-26 |
| Actual end date | 2022-09-26 |
| Shortage status | Resolved |
| Updated date | 2022-10-03 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2022-10-03 | French | Compare |
| v6 | 2022-10-03 | English | Compare |
| v5 | 2022-09-26 | French | Compare |
| v4 | 2022-09-26 | English | Compare |
| v3 | 2022-09-08 | English | Compare |
| v2 | 2022-09-07 | French | Compare |
| v1 | 2022-09-07 | English | Compare |
Showing 1 to 7 of 7